Evidence map›Paper›PMID 33975535›Full record

ArticleBMC bioinformatics2021

A detailed map of coupled circadian clock and cell cycle with qualitative dynamics validation.

Adrien Rougny, Loïc Paulevé, Michèle Teboul, Franck Delaunay

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Adrien RougnyBiotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology (AIST), Aomi, Tokyo, Japan.
Loïc PaulevéBordeaux INP, CNRS, LaBRI, UMR5800, Univ. Bordeaux, 33400, Talence, France.
Michèle TeboulCNRS, INSERM, iBV, Université Côte d'Azur, Nice, France.
Franck DelaunayCNRS, INSERM, iBV, Université Côte d'Azur, Nice, France. franck.delaunay@univ-cotedazur.fr.
Université Côte d'Azur · FRCentre National de la Recherche Scientifique · FRNational Institute of Advanced Industrial Science and Technology · JP

Funding

Agence Nationale de la Recherche ANR-14-CE09-0011
6 · The paper itself

Abstract

backgroundThe temporal coordination of biological processes by the circadian clock is an important mechanism, and its disruption has negative health outcomes, including cancer. Experimental and theoretical evidence suggests that the oscillators driving the circadian clock and the cell cycle are coupled through phase locking.

resultsWe present a detailed and documented map of known mechanisms related to the regulation of the circadian clock, and its coupling with an existing cell cycle map which includes main interactions of the mammalian cell cycle. The coherence of the merged map has been validated with a qualitative dynamics analysis. We verified that the coupled circadian clock and cell cycle maps reproduce the observed sequence of phase markers. Moreover, we predicted mutations that contribute to regulating checkpoints of the two oscillators.

conclusionsOur approach underlined the potential key role of the core clock protein NR1D1 in regulating cell cycle progression. We predicted that its activity influences negatively the progression of the cell cycle from phase G2 to M. This is consistent with the earlier experimental finding that pharmacological activation of NR1D1 inhibits tumour cell proliferation and shows that our approach can identify biologically relevant species in the context of large and complex networks.

Indexed as

Circadian ClocksAnimalsCell CycleCell DivisionCell ProliferationCircadian RhythmMammalsBiological oscillatorsBoolean modellingCell cycle checkpointsControlModel checkingReaction mapsSBGN

Identifiers

PMID33975535
PMCPMC8114686
OpenAlexW3160041858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.